Patents by Inventor Andreas Hotter

Andreas Hotter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8946441
    Abstract: The present invention relates to crystalline form I of Febuxostat as well as to pharmaceutical compositions comprising crystalline form I as an active pharmaceutical ingredient. Furthermore the present invention relates to a further polymorphic form of Febuxostat designated as form II and to a novel solvate of Febuxostat. The present invention also relates to methods of making crystalline form I, form II and the novel solvate of Febuxostat.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: February 3, 2015
    Assignee: Sandoz AG
    Inventors: Andreas Hotter, Ulrich Griesser, Verena Adamer, Christoph Langes
  • Publication number: 20140294962
    Abstract: The present invention provides a reliable process for the preparation of polymorphic pure form A of Bazedoxifene x acetate. In addition, the present invention relates to a process of wet granulation of polymorphic pure form A of Bazedoxifene x acetate. The present invention also relates to pharmaceutical compositions comprising polymorphic pure form A of Bazedoxifene x acetate as well as to the use of cyclic ethers for the preparation of such pharmaceutical composition.
    Type: Application
    Filed: December 21, 2011
    Publication date: October 2, 2014
    Applicant: SANDOZ AG
    Inventors: Arthur Pichler, Andreas Hotter, Christoph Langes
  • Patent number: 8785455
    Abstract: The present invention relates to a novel polymorph of Linagliptin benzoate and to methods for its preparation. Furthermore the present invention relates to the use of the novel polymorph for the preparation of a medicament. In addition the present invention relates to pharmaceutical compositions comprising an effective amount of the novel polymorph of Linagliptin benzoate.
    Type: Grant
    Filed: May 9, 2012
    Date of Patent: July 22, 2014
    Assignee: Sandoz AG
    Inventors: Andreas Hotter, Arthur Pichler
  • Publication number: 20140121225
    Abstract: The present invention relates to a novel polymorph of Linagliptin benzoate and to methods for its preparation. Furthermore the present invention relates to the use of the novel polymorph for the preparation of a medicament. In addition the present invention relates to pharmaceutical compositions comprising an effective amount of the novel polymorph of Linagliptin benzoate.
    Type: Application
    Filed: May 9, 2012
    Publication date: May 1, 2014
    Applicant: SANDOZ AG
    Inventors: Andreas Hotter, Arthur Pichler
  • Publication number: 20130330470
    Abstract: A method for coating the surfaces of three-dimensional objects with a coating agent is provided, which method is characterized by a blasting of the three-dimensional object, wherein a grainy blasting material that has been mixed with the coating agent is used as blasting medium.
    Type: Application
    Filed: October 10, 2011
    Publication date: December 12, 2013
    Applicant: EOS GMBH ELECTRO OPTICAL SYSTEMS
    Inventors: Mandy Gersch, Ilhan Tuncer, Andreas Hotter, Florian Pfefferkorn
  • Patent number: 8563555
    Abstract: The present invention relates to a pharmaceutical composition comprising crystalline form Y of posaconazole. The pharmaceutical composition can be used to treat or prevent fungal infections.
    Type: Grant
    Filed: May 28, 2009
    Date of Patent: October 22, 2013
    Assignee: Sandoz AG
    Inventors: Josef Wieser, Arthur Pichler, Andreas Hotter, Ulrich Griesser, Christoph Langes, Christian Laschober
  • Patent number: 8513224
    Abstract: The present invention relates to crystalline form C of Tigecycline dihydrochloride and to methods for the preparation of the same. Furthermore the present invention relates to the use of crystalline form C of Tigecycline dihydrochloride as an intermediate for the preparation of an anti-infective medicament. Moreover the present invention relates to pharmaceutical compositions comprising crystalline form C of Tigecycline dihydrochloride in an effective amount and to the use of crystalline form C of Tigecycline dihydrochloride as an anti-infective medicament.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: August 20, 2013
    Assignee: Sandoz AG
    Inventors: Andreas Hotter, Josef Wieser, Arthur Pichler, Martin Decristoforo
  • Publication number: 20130137734
    Abstract: The present invention relates to crystalline form I of Febuxostat as well as to pharmaceutical compositions camprising crystalline form I as an active pharmaceutical ingredient. Furthermore the present invention relates to a further polymorphic form of Febuxostat designated as form II and to a novel solvate of Febuxostat. The present invention also relates to methods of making crystalline form I, form II and the novel solvate of Febuxostat.
    Type: Application
    Filed: June 24, 2011
    Publication date: May 30, 2013
    Applicant: SANDOZ AG
    Inventors: Andreas Hotter, Ulrich Griesser, Verena Adamer, Christoph Langes
  • Patent number: 8435998
    Abstract: The present invention relates to crystalline form IV of posaconazole and pharmaceutical compositions comprising the same. The pharmaceutical composition can be used to treat or prevent fungal infections.
    Type: Grant
    Filed: June 25, 2009
    Date of Patent: May 7, 2013
    Assignee: Sandoz AG
    Inventors: Josef Wieser, Arthur Pichler, Andreas Hotter, Ulrich Griesser, Christoph Langes
  • Publication number: 20130012481
    Abstract: The present invention relates to crystalline forms A and B of Tigecycline hydrochloride and to methods for the preparation of the same. Furthermore the present invention relates to the use of crystalline forms A and B of Tigecycline hydrochloride as intermediates for the formulation of an anti-infective medicament. Moreover the present invention relates to pharmaceutical compositions comprising crystalline form A of Tigecycline hydrochloride in an effective amount and to the use of crystalline form A of Tigecycline hydrochloride as anti-infective medicament.
    Type: Application
    Filed: July 17, 2012
    Publication date: January 10, 2013
    Applicant: SANDOZ AG
    Inventors: Josef Wieser, Andreas Hotter, Arthur Pichler
  • Patent number: 8252946
    Abstract: The present invention relates to crystalline forms A and B of Tigecycline hydrochloride and to methods for the preparation of the same. Furthermore the present invention relates to the use of crystalline forms A and B of Tigecycline hydrochloride as intermediates for the formulation of an anti-infective medicament. Moreover the present invention relates to pharmaceutical compositions comprising crystalline form A of Tigecycline hydrochloride in an effective amount and to the use of crystalline form A of Tigecycline hydrochloride as anti-infective medicament.
    Type: Grant
    Filed: November 12, 2008
    Date of Patent: August 28, 2012
    Assignee: Sandoz AG
    Inventors: Josef Wieser, Andreas Hotter, Arthur Pichler
  • Publication number: 20120101277
    Abstract: The present invention relates to crystalline form II-S, its preparation and its use to prepare other crystalline forms of posaconazole, in particular crystalline form IV of posaconazole.
    Type: Application
    Filed: July 9, 2010
    Publication date: April 26, 2012
    Applicant: SANDOZ AG
    Inventors: Josef Wieser, Arthur Pichler, Andreas Hotter, Ulrich Griesser, Christoph Langes
  • Publication number: 20120022025
    Abstract: The present invention relates to crystalline form C of Tigecycline dihydrochloride and to methods for the preparation of the same. Furthermore the present invention relates to the use of crystalline form C of Tigecycline dihydrochloride as an intermediate for the preparation of an anti-infective medicament. Moreover the present invention relates to pharmaceutical compositions comprising crystalline form C of Tigecycline dihydrochloride in an effective amount and to the use of crystalline form C of Tigecycline dihydrochloride as an anti-infective medicament.
    Type: Application
    Filed: December 18, 2009
    Publication date: January 26, 2012
    Applicant: SANDOZ AG
    Inventors: Andreas Hotter, Josef Wieser, Arthur Pichler, Martin Decristoforo
  • Publication number: 20110124893
    Abstract: The present invention relates to the new crystalline solid form XI of Tigecycline and a process of preparing the same. Form XI of Tigecycline is particularly suitable for the isolation of Tigecycline in the last step of the synthesis of Tigecycline. Further the present invention relates to a process of preparing amorphous Tigecycline by spray drying form XI or another crystalline form of Tigecycline.
    Type: Application
    Filed: January 19, 2009
    Publication date: May 26, 2011
    Applicant: SANDOZ AG
    Inventors: Martin Decristoforo, Josef Wieser, Arthur Pichler, Andreas Hotter
  • Publication number: 20110105772
    Abstract: The present invention relates to crystalline forms A and B of Tigecycline hydrochloride and to methods for the preparation of the same. Furthermore the present invention relates to the use of crystalline forms A and B of Tigecycline hydrochloride as intermediates for the formulation of an anti-infective medicament. Moreover the present invention relates to pharmaceutical compositions comprising crystalline form A of Tigecycline hydrochloride in an effective amount and to the use of crystalline form A of Tigecycline hydrochloride as anti-infective medicament.
    Type: Application
    Filed: November 12, 2008
    Publication date: May 5, 2011
    Applicant: SANDOZ AG
    Inventors: Josef Wieser, Andreas Hotter, Arthur Pichler
  • Publication number: 20110105525
    Abstract: The present invention relates to a pharmaceutical composition comprising crystalline form Y of posaconazole. The pharmaceutical composition can be used to treat or prevent fungal infections.
    Type: Application
    Filed: May 28, 2009
    Publication date: May 5, 2011
    Applicant: SANDOZ AG
    Inventors: Josef Wieser, Arthur Pichler, Andreas Hotter, Ulrich Griesser, Christoph Langes, Christian Laschober
  • Publication number: 20110065722
    Abstract: The present invention relates to crystalline form IV of posaconazole and pharmaceutical compositions comprising the same. The pharmaceutical composition can be used to treat or prevent fungal infections.
    Type: Application
    Filed: June 25, 2009
    Publication date: March 17, 2011
    Applicant: Sandoz AG
    Inventors: Josef Wieser, Arthur Pichler, Andreas Hotter, Ulrich Griesser, Christoph Langes
  • Publication number: 20100256402
    Abstract: The present invention relates to the novel crystalline form X of Tigecycline and to processes of preparing the same. Furthermore the present invention relates to the use of crystalline form X of Tigecycline as an intermediate for the preparation of an anti-infective medicament.
    Type: Application
    Filed: November 12, 2008
    Publication date: October 7, 2010
    Applicant: Sandoz AG
    Inventors: Andreas Hotter, Josef Wieser, Arthur Pichler
  • Publication number: 20100160264
    Abstract: The present invention relates to the new crystalline solid form VI and VIII of tigecycline and processes for the production of form VI and VIII. It further relates to a new method for preparing Form I and Form III in high polymorphic purity.
    Type: Application
    Filed: June 20, 2008
    Publication date: June 24, 2010
    Inventors: Josef Wieser, Arthur Pichler, Andreas Hotter